A pilot study on feasibility, acceptance and effectiveness of metacognitive-oriented social skills training in schizophrenia
- Inchausti, F. 7
- García-Poveda, N.V. 2
- Ballesteros-Prados, A. 3
- Fonseca-Pedrero, E. 6
- Ortuño-Sierra, J. 6
- Sánchez-Reales, S. 4
- Prado-Abril, J. 1
- Aldaz-Armendáriz, J.A. 5
- Mole, J. 8
- 1 Aragon Health Sciences Institute (IACS), Complejo Hospitalario of Navarra, CSMIJ Natividad Zubieta, Sarriguren, Research Network on Preventive Activities and Health Promotion (REDIAPP) (RD12/0005), Zaragoza, Spain
- 2 CSM Ermitagaña, Complejo Hospitalario of Navarra, Pamplona, Spain
- 3 CSM Estella, Complejo Hospitalario of Navarra, Estella, Spain
- 4 CSM Jumilla, Virgen del Castillo Hospital, Murcia, Spain
-
5
Hospital Miguel Servet
info
-
6
Universidad de La Rioja
info
-
7
Universidad de Navarra
info
-
8
University of Oxford
info
ISSN: 1471-244X
Year of publication: 2017
Volume: 17
Issue: 1
Type: Article
beta Ver similares en nube de resultadosMore publications in: BMC Psychiatry
Abstract
Background: In preparation for a randomized controlled trial, a pilot study was conducted to investigate the feasibility, acceptability and effectiveness of a psychotherapy group based on metacognitive-oriented social skills training (MOSST). Methods: Twelve outpatients with schizophrenia were offered 16 group-sessions of MOSST. Effect sizes were calculated for changes from baseline to treatment end for both psychosocial functioning and metacognitive abilities measured by the Personal and Social Performance Scale (PSP) and the Metacognition Assessment Scale-Abbreviated (MAS-A) respectively. Results and discussion: Ten patients finished the full treatment protocol and nonsignificant moderate effect sizes were obtained on PSP and MAS-A scores. To date, this is the first study in Spain to suggest that outpatients with schizophrenia will accept metacognitive therapy for social skills training and evidence improvements in psychosocial functioning and metacognition. Conclusion: Despite limitations inherent in a pilot study, including a small sample size and the absence of a control group, sufficient evidence of effectiveness was found to warrant further investigation. Trial registration:ISRCTN10917911. Retrospectively registered 30 November 2016. © 2017 The Author(s).